Table 2 Univariate analysis for incidence of CRP ≥ 8 mg/L [n = 820, Mean ± SD, n (%)]
From: Factors influencing C-reactive protein status on admission in neonates after birth
Statistics | OR (95%CI) | P-value | |
|---|---|---|---|
Maternal fever | |||
No | 807 (98.41%) | 1.0 | |
Yes | 13 (1.59%) | 1.81 (0.55, 5.96) | 0.328 |
PROM | |||
No | 631 (76.95%) | 1.0 | |
Yes,<18 h | 73 (8.90%) | 1.05 (0.57, 1.95) | 0.869 |
Yes,≥18 h | 116 (14.15%) | 1.77 (1.12, 2.77) | 0.014 |
Antenatal antibiotic use | |||
No | 728 (88.78%) | 1.0 | |
Yes | 92 (11.22%) | 0.76 (0.43, 1.37) | 0.363 |
Prenatal dexamethasone use | |||
No | 649 (79.15%) | 1.0 | |
Yes | 171 (20.85%) | 0.47 (0.28, 0.77) | 0.003 |
Placenta previa | |||
No | 756 (92.20%) | 1.0 | |
Yes | 64 (7.80%) | 0.18 (0.06, 0.59) | 0.005 |
Maternal autoimmune diseases | |||
No | 797 (97.20%) | 1.0 | |
Yes | 23 (2.80%) | 4.67 (2.02, 10.78) | <0.001 |
Gestational diabetes | |||
No | 742 (90.49%) | 1.0 | |
Yes | 78 (9.51%) | 1.14 (0.65, 2.01) | 0.656 |
Pregnancy hypertension | |||
No | 759 (92.56%) | 1.0 | |
Yes | 61 (7.44%) | 1.10 (0.58, 2.08) | 0.771 |
ICP | |||
No | 791 (96.46%) | 1.0 | |
Yes | 29 (3.54%) | 0.14 (0.02, 1.03) | 0.053 |
Sex | |||
Male | 463 (56.46%) | 1.0 | |
Female | 357 (43.54%) | 0.83 (0.58, 1.18) | 0.293 |
GA | 36.07 ± 3.30 | 1.26 (1.18, 1.34) | <0.001 |
BW | 2574.49 ± 814.88 | 1.00 (1.00, 1.00) | <0.001 |
Delivery mode | |||
Vaginal delivery | 220 (26.83%) | 1.0 | |
Operative vaginal delivery | 13 (1.59%) | 1.66 (0.54, 5.11) | 0.379 |
Cesarean delivery | 587 (71.59%) | 0.31 (0.22, 0.45) | <0.001 |
Apgar score | |||
8–10 | 651 (79.39%) | 1.0 | |
4–7 | 143 (17.44%) | 1.24 (0.80, 1.92) | 0.342 |
0–3 | 26 (3.17%) | 1.91 (0.81, 4.49) | 0.139 |
MAS | |||
No | 807 (98.41%) | 1.0 | |
Yes | 13 (1.59%) | 4.87 (1.61, 14.69) | 0.005 |
NRDS | |||
No | 685 (83.54%) | 1.0 | |
Yes | 135 (16.46%) | 1.07 (0.68, 1.68) | 0.784 |
Wet lung of newborn | |||
No | 746 (90.98%) | 1.0 | |
Yes | 74 (9.02%) | 0.85 (0.45, 1.58) | 0.602 |